Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19.
Eto S, Nukui Y, Tsumura M, Nakagama Y, Kashimada K, Mizoguchi Y, Utsumi T, Taniguchi M, Sakura F, Noma K, Yoshida Y, Ohshimo S, Nagashima S, Okamoto K, Endo A, Imai K, Kanegane H, Ohnishi H, Hirata S, Sugiyama E, Shime N, Ito M, Ohge H, Kido Y, Bastard P, Casanova JL, Tanaka J, Morio T, Okada S.
Eto S, et al. Among authors: nukui y.
Res Sq [Preprint]. 2022 Mar 11:rs.3.rs-1430985. doi: 10.21203/rs.3.rs-1430985/v1.
Res Sq. 2022.
PMID: 35291303
Free PMC article.
Updated.
Preprint.